Genes located in the I region of the murine major histocompatibility complex (H-2) regulate specific immune responses to a number of antigens (1, 2). Immune response-associated (Ia) molecules found on most B cells, and to varying degrees on macrophages and T cells, are coded by genes in the 1-A and 1-E subregions and might well be the products of immune response (Ir) 1 and immune suppressor (Is) genes (2-5). Gene products of the I-J subregion, on the other hand, are found on suppressor T (Ts) cells and their soluble factors (TsF) as well as on some helper T cells (Th) and macrophages, all of which are intimately involved in the regulation of the immune response (6). Due in part to a relatively higher degree or frequency of expression, a great deal of information has been amassed as to the function, serology, and biochemistry ofl-A and I-E molecules (3, 4). In contrast, the low frequency (~5%) with which I-J-bearing cells are found in normal cells populations and the difficulty in producing anti-I-J alloantisera (7) have severely limited similar studies of 1-J gene products.
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1-,] gene products affect the immune response profoundly. Tada et al. (8) showed that a TsF specific for keyhole limpet hemocyanin (KLH) bears determinants encoded by the 1-J subregion. These findings were subsequently confirmed by Theze et al. (9) for a poly(GluU~'l'yrt'~)(GT)-specific TsF and by Greene et al. (10) for an azobenzene arsonate-specific TsF. Pierres et al. (11, 12) demonstrated that the administration of microliter quantities of anti-I-J serum to GT-suppressor strain mice allowed them to make a GT-specific antibody response apparently due to the elimination or inactivation of I-J-bearing Ts. Likewise, Greene et al. (13) showed that alloanti-I-J, when administered to S1509a fibrosarcoma-bearing mice, caused regression of the tumor due to the inactivation of tumor-induced Ts. In addition, Tada et al. (14) demonstrated that KLH-specific Ts bear antigenic determinants distinct from those found on I-J + Th, suggesting that at least two distinct genes are located within the l-J subregion. It may well be that the 1-J subregion is composed of a cluster of regulatory genes whose products are selectively expressed on Ts, Th, and macrophages. Although cell absorbtion studies have been useful in the identification of differing 1-J gene products, critical evaluation of the heterogeneity of the 1-J subregion genes and their products is limited when aUoantisera are used. The introduction of somatic B cell hybridization technology has allowed the production of large quantities of monoclonal antibodies (mAb). These monospecific antibodies should allow the further elucidation of the function and biochemistry of Ia molecules. In this paper I report the preparation and properties of a series of mAb directed against gene products of the I-J b and 1-J k subregions. These mAb were selected for their functional effect(s) upon normal spleen cell populations: first, for their ability to allow GT-suppressor mice to respond to GT immunization both in vitro and in vivo, and subsequently for their ability to bind GT-TsF of the appropriate haplotype. Some mAb bind GT-TsF, indicating a heterogeneity of 1-J gene products. In addition, an I-J k monoclonal GT-TsF (mGT-TsF) has been produced that is specifically bound by anti-I-J k mAb. The implications of these findings and reagents to the further characterization of the 1-J subregion and its products are discussed.
Materials and Methods
Mice. BALB Antigens. Poly(GluS°TyrS°)(GT), lot 9, originally purchased from Miles Laboratories, Inc., Elkhardt, Ind., was the generous gift of Dr. Baruj Benacerraf, Harvard Medical School. Poly(Glun°Alan°TyrW)(GAT), lot 1, and methylated bovine serum albumin (MBSA) were purchased from Vega-Fox Bioehemieals Div., Newberg Energy Corp., Tucson, Ariz. GAT, GT, and their MBSA complexes were prepared as previously described (15) .
Alloantisera. Alloantisera to the I-J k subregion were prepared by injecting (DBA/2 × 3R)FI mice biweekly with 107 spleen and thymus cells from 5R female mice. Anti-I-J b were similarly prepared by injecting (DBA/2 × 5R)F1 mice biweekly with 107 lymphoid cells from female 3R mice. In the preparation of both types of alloantisera, recipient mice were bled following the seventh biweekly immunization and were immunized and bled on alternate weeks thereafter.
Production of Hybridomas. B cell hybridomas secreting anti-I-J antibodies were derived from the somatic cell fusion of hyperimmune spleen cells with the hypoxanthine phosphoribosyl transferase-negative myeloma cell line, P3X63Ag8. Briefly, a single cell suspension of (DBA/2 × 3R)Fs spleen cells was prepared 13 d after the 12th biweekly immunization of these F1 mice with 10 7 5R lymphocytes. 39 × 106 (DBA/2 × 3R)F1 hyperimmune spleen cells were admixed with 3.9 × 10 e P3X63Ag8 myeloma cells in serum-free Duibecco's minimum essential medium (DME) and centrifuged into a loosely packed pellet. 1 ml of polyethylene glycol (PEG, diluted to 50% [vol/vol] with serum-free DME) was added dropwise to fuse the cell membranes (16) . The fusion mixture was diluted to 50 ml with serum-free DME over 15 rain. The cells were washed to remove the PEG, resuspended to 30 ml in DME plus 10% fetal calf serum (FCS), and dispensed into 96-well mieroculture plates (Linbro Chemical Co., Hamden, Conn.; 76-003-05) to a total of 384 wells. Each well received 5 × 104 normal spleen cells from (DBA/2 × 3R)F1 mice as "feeder" cells. The cultures were incubated for 48 h at 37°C in 10% CO2. Hybridoma cells were positively selected by elimination of the parent myeloma using hypoxanthine-aminopterin-thymidine (HAT)-containing selective medium (17) . Cultures were fed every other day by one-half medium replacement with HAT-DME plus 10% FCS for 7 d, followed by HT-DME plus 10% FCS for 7 d, and, finally, the cells were maintained in DME plus 10% FCS. Approximatel~ 95% of the seeded wells showed cellular growth a'fter the HAT-selection procedure. Anti-I-J -secreting hybridomas were similarly prepared from the fusion of 3R-immunized (12th immunization) (DBA/2 × 5R)F1 spleen cells with P3X63Ag8. Anti-I-Jsecreting hybrids were selected as detailed in Results. Selected cell lines were established as monocional by the isolation of individual colonies in soft agar, as previously described (18) . At various stages of the selection procedure, hybrid cell lines were cryopreserved in 2-ml aliquots containing no less than 106 viable cells/ml in DME plus 20% FCS plus 10% dimethylsulfoxide and stored at -85°C.
T cell hybridomas producing GT-TsF were prepared in a manner similar to that described above for the B cell hybridomas. Preparation of GT-TsF. GT-TsF was prepared as previously described (19) (20) (21) Preparation and Use of Immunoadsorbent Columns. Immunoadsorbent columns were prepared as previously described (20) . Hybridoma culture supernates or ascites fluids from hybridomabearing mice were heat inactivated for 30 rain at 56°C. Immunoglobulin-rich fractions were prepared by precipitation with 50% ammonium sulfate and extensively dialyzed against 0.5 M NaC1-0.1 M NaCOa. The globulin-rich fractions were coupled to CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals, Div. of Pharmaeia, Inc., Piscataway, N. J.) at a final protein concentration of 2 mg/ml packed gel. In all cases, coupling efficiency, as judged by UV absorbtion, was >90%. Immunoadsorbents were stored in phosphate-buffered saline (PBS) containing 0.2% NaNa. Before use, gels were packed in 3-ml plastic syringes to serve as columns and washed with 10-25 vol of PBS in the absence of azide. GT-TsF, diluted 1:10, was applied to the columns always in a volume equal to or less than one-half the void volume of the gel. The GT-TsF were incubated in the gel bed for 15 min at 24°C, fresh PBS was applied to the column, and the effluent was collected. Columns were then washed with at least 10 vol of PBS, 0.1 M glycine-HC1 buffer, pH 2.5, applied to the column, and the acid eluate was collected and immediately neutralized to pH 7.1-7.3 with the appropriate quantity of 2 M Tris. Effluent and eluate materials were immediately filter sterilized (0.45-#m filter) and added to Mishell-Dutton cultures at the final concentrations indicated in Tables I and III . In one series of experiments, an anti-idiotype immunoadsorbent column was used. This column was the generous gift of Dr. S.-T. Ju and Dr. M. E. Dorf, Department of Pathology, Harvard Medical School. Anti-idiotype antibodies (anti-CGAT) (22) for the common anti-GAT idiotype were bound to CNBr-aetivated Sepharose 4B at 1 mg protein/ml packed gel. Adsorptions and elutions from the column were performed exactly as described above.
Immunizations. AKR/Cum and B10.BR mice were immunized with 10 p.g GT in Maalox and Bordetella pertussis i.p. as adjuvant immediately after intravenous injection of monoclonal anti-I-J antibodies. 7 d later the number of GT-specific plaque-forming cells (PFC) per spleen were determined.
In Vitro Cultures. Spleen cells ofBALB/c, AKR/Cum, B6, B10, or BI0.BR mice were placed in a modified Mishell-Dutton culture system. In brief, 8 X 10 e spleen cells were cultured for 5 d in 0.5-ml cultures in a 24-well tissue culture plate (Linbro 76-033-05) in standard MishellDutton culture medium (23) containing 5 X 10 -s M 2-mercaptoethanol and 10% FCS (lot 2851, Pel-Freez Biologicals Inc., Rogers, Ark.). 5 #g GAT, 10 #g GT, or 10 #g GT as GT-MBSA were added at culture initiation. Alloanti-I-J antisera, hybridoma culture supernates, ascites fluids from hybridoma-bearing mice, and/or GT-TsF was/were added as indicated in the figures and the table legends. Cultures were fed daily with 120 #1 of a mixture of 50% nutritional cocktail and 50% FCS. Cultures were incubated at 37°C with rocking in a moist atmosphere containing 83% N2, 10% CO2, and 7% 02. 5 d after the establishment of culture, the number of GT-specific PFC per culture was enumerated.
Hemolytic Plaque Assay. The anti-GAT and anti-GT PFC response was assayed by a modification of the Jerne hemolytic plaque technique (20) . Indicator cells were prepared by coupling GAT to sheep erythrocytes by the CrC13 method. Data obtained are expressed as number of PFC per spleen or PFC per culture.
Results
Effect of Anti-I-J Alloantisera In Vitro. In our laboratory we are studying the regulatory role(s) of I-J gene products expressed selectively on different macrophage and lymphoid cell populations. To this end, we have produced a panel of monoclonal antibodies (mAb) to gene products of the I-J subregion. The major obstacle to the identification of mAb directed against I-J gene products by the microcytotoxicity assay is the low frequency with which I-J-bearing cells are found in normal cell populations (7). We decided not to use selected Ts or I-J-bearing tumor cell populations because this might not have expressed a full repertoire of I-J specificities and, consequently, might have skewed our results by allowing us to detect only a limited subset of mAb directed against I-J specificities. Instead, we chose to use a functional assay to screen for anti-I-J mAb. Although the binding of TsF to an anti-I-J immunoadsorbent column was one of the criteria originally used to identify I-J gene Fro. 1. In vitro augmentation of GT-specific PFC by hybridoma culture supernates. AKR/Cum spleen cells were placed in Mishell-Dutton-type culture conditions for 5 d in the presence of 10 #g GT/culture well and 25 #1 of WF8 series culture supernates were added to cultures at a 1:400 final dilution. The letter-numbers designate the hybridoma. The asterisk above the vertiele bar denotes the cell lines whose supernates were tested for their ability to bind GT-TsF, Table II, experiment I. products (8), the large number of hybrids obtained from a somatic B cell fusion makes this type of initial screening approach both costly and difficult to perform. Therefore, we asked whether anti-I-J antibody would augment PFC response in vitro. B6 (I-J b)
spleen cells were placed in Mishell-Dutton-type cultures with suboptimal concentration (5 #g/ml) of GAT (Table I) (Table I) , whereas the addition of anti-I-J b antibody caused only minimal enhancement. This provided us with a rapid and simple method for the detection of anti-I-J activity. 
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TABLE III

Absorption of Monoclonal Anti-I-J Antibody Activity by B I O.A ( 3R ) and B I O.A ( 5R ) Lymphocytes
Strain Antigen §
Additions to culture~
Antibody Absorption GT-specific PFC per culture* Final anti-I-J dilution Control 1: 1: 1: 4,000 40,000 400,000 GT-MBSA -- supernates were screened for their effect on the GT responsiveness of AKR/Cum spleen cells in vitro (Fig. 1) . Cultures containing only GT produced <60 PFC per culture. A number of those wells receiving hybridoma culture supernates showed a marked enhancement of GT-speeific PFC. The great frequency with which these supernates allow a GT-suppressor strain to make a GT response, shown in Fig. 1 , is most likely due both to the use of hyperimmune animals in the fusion and to the fact that this is a second-phase screening from preselected wells. Subsequent screenings performed in this manner revealed that some hybridomas showed a more consistent pattern of augmentation than others. Seven of these, each indicated by an asterisk, were selected for subsequent testing.
Adsorption of GT-TsF by Hybridoma Culture Supernates. Although indicative of anti-I-
J activity, the screening procedure described above is by no means conclusive proof.
Because determinants encoded by the I-J subregion have been shown to be associated with soluble TsF (8-10), we wished to establish whether those supernates that augment a PFC response in vitro can also bind GT-TsF. Accordingly, the heat-inactivated immunoglobulin fractions of the hybridoma cultures indicated by an asterisk in Fig.  1 were coupled to CNBr-Sepharose and used as immunoadsorbent columns for the third screening phase. B10.BR (I-J k) GT-TsF was incubated on the hybridoma immunoglobulin-Sepharose columns. B10.BR GT-TsF normally causes near total suppression of the GT-MBSA PFC response of BALB/c spleen cells in vitro at a 1:400 final dilution (Table II , experiment I). Supernates from five of the anti-I-J k hybridoma cultures (WF8 series; A12, B6, C2, C12, and D2) bound GT-TsF and two (B2 and D1) did not. Adsorbed GT-TsF can be eluted from the columns with glycine-HCl buffer, pH 2.5, with no loss of suppressive activity (Table II and Table I . Six hybridoma-containing wells were further tested for their ability to bind I-J b GT-TsF (Table II, (Table V) . This suppressive material can be adsorbed by and eluted from a monoclonal anti-I-J k (WF8.C12.8) immunoadsorbent column. Recently, Ju et al. (22) described an anti-idiotype antibody (termed anti-CGAT) that recognizes the predom-inant idiotypic determinants on anti-GAT and anti-GT antibodies. Because initial studies showed that our monoclonal GT-TsF specifically binds to GT-Sepharose columns, we asked whether WF 11.3.A 1-derived GT-TsF bears idiotypic determinants recognized by anti-CGAT anti-idiotype antibodies. The suppressive material eluted from the WF8.C 12.8 immunoadsorbent column (Table V) was incubated on an anti-CGAT column. Table V shows that our monoclonal GT-TsF, which is bound by anti-I-J ~ mAb, is also bound by and can be eluted from the anti-idiotype column. Therefore, the same monoclonal GT-TsF bears both I-J and idiotypic determinants. Studies are currently in progress to determine the biochemical association of these two determinants. Discussion I-J subregion genes or their products appear to be intimately involved in several aspects of immune regulation. The marker locus for the 1-J subregion, Ia-4, codes for antigenic determinants on Ts and TsF (7) (8) (9) (10) 24) , whereas other Ia loci contained within the I-J subregion apparently code for determinants found on Th and macrophages (7). The selective expression of different I-J gene products on functionally distinct populations of lymphocytes and macrophages provides a potentially powerful model for the investigation of genetic regulation of the immune response. Major drawbacks to such studies have been both the limited availability of adequate anti-I-J alloantisera (28) and the relative heterogeneity of such sera with respect to/-jr gene products (14) . Lack of intra-I-J recombinant mouse strains also hinders definition of additional Ia loci and/or gene products within the subregion. A promising approach to the identification of/-region gene products is to use monoclonal antibodies (mAb) directed against individual antigenic determinants. I report the establishment of a panel of mAb directed against gene products of the l-J a and I-J ~ subregions. These mAb are secreted by hybridoma B cell lines derived from the fusion of the P3X63Ag8 myeloma cell line with either (DBA/2 × 3R)F1 anti-5R or (DBA/2 × 5R) anti-3R hyperimmune spleen cells. The resultant hybridoma antibodies were assayed in a twostage functional assay procedure. Putative anti-I-J antibodies were first assayed for their ability to augment a humoral immune (PFC) response both in vitro and in vivo. The anti-I-J mAb are active in causing nonresponder mice, or mice receiving suboptimal concentrations of antigen, to respond to antigenic challenge both in vivo and in vitro. A select number of these mAb were tested in a second-stage functional assay for their ability to bind I-J-bearing GT-TsF. Some of the anti-I-J mAb bind TsF, indicating that they may recognize different I-J gene products. (24, 25) , I have observed no such cross reactivity with either the WF8 or WF9 series of mAb (unpublished observations). The lack of cross-reactivity with I-J b products by our anti-I-J b mAb is most likely due to the use of (H-2 a × H-2~)F1 mice as one of the fusion partners. Further studies are currently in progress to determine whether either the anti-I-J k or anti-I-J b mAb cross-react with other I-J specificities.
experiment II). Similar to our findings with the WF8 series of
The two-stage functional screening assay for the identification of anti-I-J mAb is both simple and rapid. Furthermore, in those lacking the appropriate recombinational event that allows the production of monospecific anti-I-J alloantibody, monoclonal anti-I-J hybridoma antibodies can be selected using this technique. We are currently I-J gene products have been shown to be present on antispecific TsF (8) (9) (10) . In addition, intravenous administration of microliter quantities of alloanti-I-J antibodies to mice has been shown to augment humoral (I I, 12) and cellular (13) immunity, apparently through the inactivation of Ts. There is no evidence that antibodies directed against I-J determinants on antigen-specific TsF are the same as those that augment an immune response. Our experiments show that anti-I-J mAb that binds TsF also causes augmentation of a PFC response (Table II and Fig. I ). This is not to say, however, that all hybridoma anti-I-J antibodies both augment a humoral response and bind TsF. Table II , experiment I, clearly shows that of seven hybridoma anti-I-J antibodies, all of which cause augmentation of the GT PFC response in vitro, only five bind I-J k GT-TsF. This suggests that alIoantisera contain antibodies directed against several different I-J gene products that are individually recognized by anti-I-J mAb. That some mAb bind TsF and augment the PFC response might indicate that these antibodies are directed against gene products expressed at only one stage in the suppressor pathway (i.e., the anti-I-J mAb might be directed against gene products expressed on the TsF-producing [Tsl] ceil). Those mAb that augment a PFC response but do not bind TsF may be directed against I-J determinants selectively expressed by a different subset of ceils, representing another stage in the suppressive pathway. The use of anti-I-J mAb should allow the further elucidation of the suppressor pathway.
Little is known about the biochemistry of l-ff gene products. Monoclonal anti-I-J antibodies should provide a valuable tool in the biochemical characterization of l-ff gene products. We have been successful in producing monoclonal GT-TsF by fusing spleen ceils from GT-primed BI0.BR (I-ff k) mice with the BW5147 thymoma. Table   V shows that the culture supernate from one such hybridoma T cell line, WFI 1.3.AI, contains a suppressive material that can be sequentially bound by anti-I-J k mAb (WF8.C12.8) and by anti-idiotype (anti-CGAT). This clearly demonstrates that monoclonal GT-TsF bears both I-J k and idiotypic determinants on the same molecule or molecular complex. The use of both monoclonal GT-TsF and anti-I-J mAb should provide powerful tools in the further biochemical and functional characterization of a functional I-ff gene product.
Finally, it should be noted that evidence accumulating from other laboratories that have been assaying our monoclonal anti-I-J antibodies has demonstrated that they are cytotoxic for azobenzene arsonate Tsl cells and that they bind Ars-specific TsF Therefore, it appears that anti-I-J mAb are useful in the identification of I-J gene products in antigenic systems other than GT and that these antibodies might prove to be a powerful tool for the further delineation of I-J subregion gene(s) and their products.
Summary
Using a novel, two-step functional screening procedure, we have isolated hybridoma B cell lines secreting monoclonal antibodies directed against gene products of the I-J b and I-J k subregions of the mouse H-2 complex. These monoclonal antibodies act in vitro by allowing nonresponder spleen cells to respond to normally suppressive quantities of poly(Glu~Tyr 5°) (GT) (WF8 series of anti-I-J k monoclonal antibodies) or to suboptimal concentration of poly(Glu~°Ala~Fyr l°) (WF9 series of anti-I-J b monoclonal antibodies). Some of the culture supernates that show augmenting activity bind GT-specific T cell-derived suppressor factor (GT-TsF), indicating that some monoclonal antiantibodies display a nonspecific enhancing effect, or, more likely, that anti-I-J monoclonal antibodies have been produced against I-J determinants not found on TsF. It is this last possibility that is most intriguing and that might serve as a means for exploring the heterogeneity of the I-J subregion. It is also possible that some of our monoclonal anti-I-J antibodies might detect antigenic determinants selectively expressed on suppressor T cells, helper T cells, and/or macrophages. In addition, we have demonstrated that monoclonal anti-I-J antibodies should be useful in the biochemical characterization and purification of a monoclonal GT-TsF. These haplotype-specific anti-I-J monoclonal antibodies should prove to be powerful tools for future studies exploring the role of I-J gene products in the regulation of specific immune responses.
